SMARCE1 Gene Meningioma Familial Susceptibility to Genetic Test
Welcome to DNA Labs UAE, a leading genetic lab offering a comprehensive range of genetic tests. In this blog post, we will discuss the SMARCE1 Gene Meningioma familial susceptibility to genetic test, its components, cost, symptoms, diagnosis, and more.
Test Details
The SMARCE1 gene is associated with a condition called familial meningioma, which is a genetic susceptibility to develop meningiomas. Meningiomas are tumors that originate in the meninges, the protective membranes that surround the brain and spinal cord.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations that may contribute to the development of certain diseases or conditions. In the case of familial meningioma, NGS genetic testing can identify mutations or variants in the SMARCE1 gene that may increase the risk of developing meningiomas.
This type of genetic testing can be helpful for individuals with a family history of meningiomas, as it can provide information about their personal risk of developing the condition. It can also be used for genetic counseling and to inform medical management and screening recommendations for at-risk individuals.
It’s important to note that genetic testing for familial meningioma is typically performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics. They can provide appropriate counseling and guidance based on the individual’s test results and family history.
Test Name
SMARCE1 Gene Meningioma familial susceptibility to Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test gene SMARCE1.
For more information or to schedule a test, please contact our Genetics Test Department.
Test Name | SMARCE1 Gene Meningioma familial susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMARCE1 Gene Meningioma, familial, susceptibility to NGS Genetic DNA Test gene SMARCE1 |
Test Details |
The SMARCE1 gene is associated with a condition called familial meningioma, which is a genetic susceptibility to develop meningiomas. Meningiomas are tumors that originate in the meninges, the protective membranes that surround the brain and spinal cord. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations that may contribute to the development of certain diseases or conditions. In the case of familial meningioma, NGS genetic testing can identify mutations or variants in the SMARCE1 gene that may increase the risk of developing meningiomas. This type of genetic testing can be helpful for individuals with a family history of meningiomas, as it can provide information about their personal risk of developing the condition. It can also be used for genetic counseling and to inform medical management and screening recommendations for at-risk individuals. It’s important to note that genetic testing for familial meningioma is typically performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics. They can provide appropriate counseling and guidance based on the individual’s test results and family history. |